Related Experiment Video
Updated: Mar 23, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Nobel prize-winning Treg cells in autoimmune kidney diseases and transplantation
Griffith B Perkins1, Maarten Naesens2
1Centre for Clinical and Experimental Transplantation, School of Medicine, Adelaide University, Adelaide, South Australia, Australia; Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Abstract:
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their research into mechanisms by which the immune system avoids attacking the body's own tissues. At the heart of this research was the discovery of the regulatory T cell, a peculiar immune cell with the capacity to shut down autoimmunity. This Editorial: Special Report looks at the tenacious science and scientists behind the discovery of the regulatory T cell, and the clinical progress of regulatory T-cell therapies to treat autoimmune kidney diseases and transplant rejection.
Related Concept Videos
Kidney Transplant I: Introduction
Cell-mediated Immune Responses
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

